For a long time, menstrual blood was largely overlooked in medical research. Over the past 15 to 20 years, that has started to change. Scientists have identified cell populations in menstrual blood with properties similar to mesenchymal stromal/stem cells, making this an active and increasingly interesting area of regenerative medicine research.
The field is real, but it is still developing. Most findings so far come from laboratory and animal studies, with only limited early-stage clinical research in humans.
What Is Found in Menstrual Blood?
Menstrual blood contains shed material from the lining of the uterus, known as the endometrium. Among the cells isolated from menstrual fluid are populations commonly referred to as menstrual blood-derived stem cells, or MenSCs.
These cells were first described in 2007 and have since been studied for several features associated with mesenchymal stromal/stem cell-like populations, including:
- the ability to self-renew in culture
- the ability to differentiate into multiple cell types under laboratory conditions
- strong proliferation in vitro
- immunomodulatory effects, meaning they can influence immune signaling and immune cell behavior
These characteristics make MenSCs scientifically important. At the same time, researchers still debate how broadly such cultured cells should be described as true “stem cells,” so it is more accurate to say they are MSC-like cell populations with promising biological properties.
Why Menstrual Blood Is an Interesting Cell Source
Compared with more traditional sources such as bone marrow or adipose tissue, menstrual blood has several advantages for research:
- Non-invasive collection
Cells can be collected from menstrual fluid without surgery or needle-based harvesting.
- Repeated availability
Because menstruation is cyclical, this source can be available repeatedly over time rather than through a single collection procedure.
- Fewer ethical concerns
These are adult-derived cells, so they do not raise the same ethical issues associated with embryonic stem cells.
- Strong expansion in lab studies
Some studies suggest MenSCs can be expanded through multiple passages in culture while maintaining key characteristics. However, long-term genomic stability and standardization remain important questions for future clinical use.
How Are Menstrual Blood-Derived Cells Being Studied?
Researchers are investigating MenSCs in several areas of medicine. Most of these applications are still experimental.
- Regenerative Medicine and Tissue Repair
MenSCs are being studied for their potential role in tissue healing and repair.
Preclinical research has reported:
- improved recovery in some stroke and cardiac injury models
- support for wound healing and tissue regeneration in animal studies
- reduced inflammation and cell death in some neurological disease models
Importantly, these effects may come not only from cell differentiation, but also from the signaling molecules the cells release, which can influence healing in surrounding tissue.
- Reproductive Health and Fertility
Because these cells are derived from menstrual fluid and linked to endometrial biology, they are of particular interest in gynecology and reproductive medicine.
Current areas of study include:
- endometrial repair and regeneration
- Asherman’s syndrome
- infertility related to endometrial dysfunction
- possible support for implantation in selected settings
There have been early clinical studies and trials in this area, but they are still small and preliminary.
- Immune and Inflammatory Conditions
MenSCs appear to interact with the immune system in complex ways. Experimental studies suggest they may:
- influence immune cell activity, including natural killer cells
- reduce inflammatory signaling in some disease models
This makes them relevant to research on inflammatory and immune-mediated diseases, although clinical applications remain unproven.
- Chronic and Degenerative Disease Research
MenSCs are also being explored in preclinical models of conditions such as:
- diabetes
- neurodegenerative diseases, including Parkinson’s disease
These findings are promising, but they are still largely limited to laboratory and animal research.
Where the Science Stands Today
It is important to be precise about the current state of evidence.
At present:
- most MenSC research is still preclinical
- human trials are limited and early-stage
- no widely established standard therapies based on menstrual blood-derived cells currently exist
So while this is a legitimate and promising area of science, it is not yet a mainstream medical treatment.
Why This Research Matters
The importance of this field goes beyond the cells themselves.
Menstrual blood research highlights:
- a biological resource that was historically underused
- the potential for less invasive approaches in regenerative medicine
- growing recognition that female-specific biology has often been understudied
Menstrual blood-derived cells represent only a very small share of the broader stem cell literature, which suggests the field still has substantial room to grow.
What the Future May Hold
If ongoing research continues to produce strong results, menstrual blood-derived cells could contribute to:
- more personalized regenerative therapies
- less invasive approaches in reproductive medicine
- new strategies for inflammatory disease research
- better understanding of endometrial health and disorders such as endometriosis
To reach that point, the field will need:
- larger and better-controlled clinical trials
- standardized collection, isolation, and processing methods
- more long-term safety data
- clearer definitions of which cell populations are most clinically useful
Menstrual blood is not simply biological waste. It is a biologically active material that can contain cell populations with regenerative and immunomodulatory potential.
Research in this area is still early, but it is scientifically credible and expanding. As the field develops, it may open important new directions in regenerative medicine and women’s health research.